Skip to main content
Clinical Trials/NCT00725257
NCT00725257CompletedNot Applicable

Effect of a Low-Carbohydrate Mediterranean Diet or Low-Fat Diet in Newly-Diagnosed Type 2 Diabetic Patients

University of Campania "Luigi Vanvitelli"1 site in 1 country215 target enrollmentStarted: June 1, 2004Last updated:
Conditions
Interventions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Enrollment
215
Locations
1
Primary Endpoint
Hemoglobin A1c

Study Overview

Brief Summary

The major environmental factors that increase the risk of type 2 diabetes, presumably in the setting of genetic risk, are overnutrition and a sedentary lifestyle, with consequent overweight and obesity. The high rate of weight regain has limited the role of lifestyle interventions as an effective means of controlling glycemia long term. The aims of the present study were: 1) To compare the effectiveness and safety of two nutritional protocols - namely low-carbohydrate Mediterranean diet or low-fat diet - in newly-diagnosed, drug-naive overweight patients with type 2 diabetes mellitus. The primary aim of the study was the effect on hemoglobin A1c levels; secondary aims were time to introduction of the first hypoglycemic agent, prevalence of the metabolic syndrome, percentage of patients meeting ADA goals for risk factors (HbA1c, blood pressure, LDL-cholesterol, percentage of patients with HbA1c < 7%.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Treatment
Masking
None

Eligibility Criteria

Ages
30 Years to 75 Years (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • •Type 2 diabetes mellitus (ADA criteria)
  • •BMI (body mass index) > 25 kg/M2
  • •Hemoglobin A1c (HbA1c) < 11%; Blood pressure < 160 (systolic) and 100 (diastolic) mm Hg
  • •Triglyceride levels < 500 mg/dl.

Exclusion Criteria

  • •Pregnancy or breast-feeding
  • •Previous use of insulin or oral antidiabetic drugs
  • •Investigational drug within the previous 3 months
  • •Use of agents affecting glycemic control (systemic steroids and weight loss drugs)
  • •Patients with history of alcohol or illicit drug abuse
  • •Patients with liver enzymes higher than three times the upper limit of normal
  • •Serum creatinine > 1.4 mg/dl.

Arms & Interventions

1

Active Comparator

Low-carbohydrate, energy-restricted, Mediterranean-type diet

Intervention: Mediterranean diet (Other)

2

Active Comparator

Low-fat diet

Intervention: Low-fat diet (Other)

Outcomes

Primary Outcomes

Hemoglobin A1c

Time Frame: Every sixth month

Secondary Outcomes

  • Time to introduction of an oral hypoglycemic agent(Every year)

Investigators

Study Sites (1)

Loading locations...

Similar Trials